These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25263095)

  • 21. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT; Memiş D; Kargi M; Sut N
    J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
    Levesque E; Saliba F; Benhamida S; Ichaï P; Azoulay D; Adam R; Castaing D; Samuel D
    Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.
    Umbro I; Tinti F; Mordenti M; Rossi M; Ianni S; Pugliese F; Ruberto F; Ginanni Corradini S; Nofroni I; Poli L; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1139-41. PubMed ID: 21620072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive Value of Indocyanine Green Plasma Disappearance Rate on Liver Function and Complications After Liver Transplantation.
    Sun Y; Yu L; Liu Y
    Med Sci Monit; 2018 Jun; 24():3661-3669. PubMed ID: 29855460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does model for end-stage liver disease (MELD) require modification?
    Desai HG
    J Assoc Physicians India; 2011 Jun; 59():372-3. PubMed ID: 21751591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients.
    Halle BM; Poulsen TD; Pedersen HP
    Acta Anaesthesiol Scand; 2014 Nov; 58(10):1214-9. PubMed ID: 25307706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indocyanine green dye clearance test: early graft (dys)-function and long-term mortality after liver transplant. Should we continue to use it? An observational study.
    Cherchi V; Vetrugno L; Zanini V; Isler T; Pravisani R; Borghi A; Baccarani U; Terrosu G; Risaliti A; Bove T
    J Clin Monit Comput; 2021 May; 35(3):505-513. PubMed ID: 32166552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of short term outcome after liver transplantation: A review.
    Bolondi G; Mocchegiani F; Montalti R; Nicolini D; Vivarelli M; De Pietri L
    World J Gastroenterol; 2016 Jul; 22(26):5936-49. PubMed ID: 27468188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation.
    Schneider L; Spiegel M; Latanowicz S; Weigand MA; Schmidt J; Werner J; Stremmel W; Eisenbach C
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):362-8. PubMed ID: 21813383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure.
    Merle U; Sieg O; Stremmel W; Encke J; Eisenbach C
    BMC Gastroenterol; 2009 Dec; 9():91. PubMed ID: 19954554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test.
    Stockmann M; Lock JF; Malinowski M; Seehofer D; Puhl G; Pratschke J; Neuhaus P
    Transpl Int; 2010 Oct; 23(10):1023-32. PubMed ID: 20444241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased long-term survival among patients with hepatocellular carcinoma after implementation of Model for End-stage Liver Disease score.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Cho-Phan C; Nguyen MH
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1534-40.e1. PubMed ID: 24361414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients.
    Reekers M; Simon MJ; Boer F; Mooren RA; van Kleef JW; Dahan A; Vuyk J
    Anesth Analg; 2010 Feb; 110(2):466-72. PubMed ID: 20081133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Plasma Disappearance Rate Indocyanine Green Clearance as a Predictor of Liver Graft Rejection in Donor Brain Death.
    Asencio JM; Cortese S; López Baena JA; Olmedilla L; Pérez Peña JM; Salcedo MM; Matilla A; Martín L; Martínez C; Orue-Echebarria MI; Lozano P
    Transplant Proc; 2020 Jun; 52(5):1472-1476. PubMed ID: 32217011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.